MRK Jan 2025 80.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 01:15PM EST. Market open.
| Previous close | 3.2500 |
| Open | 3.3000 |
| Bid | 2.9000 |
| Ask | 3.9500 |
| Strike | 80.00 |
| Expiry date | 2025-01-17 |
| Day's range | 3.2500 - 3.3000 |
| Contract range | N/A |
| Volume | |
| Open interest | 94 |
- Simply Wall St.
Merck (NYSE:MRK) Has Announced That It Will Be Increasing Its Dividend To $0.73
Merck & Co., Inc. ( NYSE:MRK ) will increase its dividend from last year's comparable payment on the 10th of April to...
- Business Wire
FDA Approves KEYTRUDA® (pembrolizumab) as Adjuvant Treatment Following Surgical Resection and Platinum-Based Chemotherapy for Patients With Stage IB (T2a ≥4 Centimeters), II, or IIIA Non-Small Cell Lung Cancer (NSCLC)
RAHWAY, N.J., January 27, 2023--FDA Approves KEYTRUDA as Adjuvant Treatment Following Surgical Resection and Chemotherapy for Patients With Stage IB (T2a ≥4 cm), II, or IIIA NSCLC
- Zacks
Merck (MRK) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
Merck (MRK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
© 2023 Yahoo. All rights reserved.
